36011337 36139708 34145320 32674367 33314312 34548497 33453941 35661019 35427743 35347144 36675159 35723115 35755775 33206398 33526455 34414419 36590101 36088364 33494262 34511867 34439767 35143968 33750819 33291304 34058741 33986285 - Search Results

Year	Number of Results
2020	4
2021	13
2022	10
2023	1

1

Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.

Thakur G, Kumar V, Lee KW, Won C. Thakur G, et al. Genes (Basel). 2022 Aug 11;13(8):1426. doi: 10.3390/genes13081426. Genes (Basel). 2022. PMID: 36011337 Free PMC article. Review.

2

LRRK2 Inhibition by PF06447475 Antagonist Modulates Early Neuronal Damage after Spinal Cord Trauma.

Filippone A, Mannino D, Cucinotta L, Paterniti I, Esposito E, Campolo M. Filippone A, et al. Antioxidants (Basel). 2022 Aug 23;11(9):1634. doi: 10.3390/antiox11091634. Antioxidants (Basel). 2022. PMID: 36139708 Free PMC article.

3

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10.

Wang X, Negrou E, Maloney MT, Bondar VV, Andrews SV, Montalban M, Llapashtica C, Maciuca R, Nguyen H, Solanoy H, Arguello A, Przybyla L, Moerke NJ, Huntwork-Rodriguez S, Henry AG. Wang X, et al. Sci Rep. 2021 Jun 18;11(1):12900. doi: 10.1038/s41598-021-91943-4. Sci Rep. 2021. PMID: 34145320 Free PMC article.

4

Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.

Pajares M, I Rojo A, Manda G, Boscá L, Cuadrado A. Pajares M, et al. Cells. 2020 Jul 14;9(7):1687. doi: 10.3390/cells9071687. Cells. 2020. PMID: 32674367 Free PMC article. Review.

5

Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.

Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, Tansey MG. Kline EM, et al. Mov Disord. 2021 Jan;36(1):25-36. doi: 10.1002/mds.28411. Epub 2020 Dec 14. Mov Disord. 2021. PMID: 33314312 Free PMC article. Review.

6

Fine mapping of the HLA locus in Parkinson's disease in Europeans.

Yu E, Ambati A, Andersen MS, Krohn L, Estiar MA, Saini P, Senkevich K, Sosero YL, Sreelatha AAK, Ruskey JA, Asayesh F, Spiegelman D, Toft M, Viken MK, Sharma M, Blauwendraat C, Pihlstrøm L, Mignot E, Gan-Or Z. Yu E, et al. NPJ Parkinsons Dis. 2021 Sep 21;7(1):84. doi: 10.1038/s41531-021-00231-5. NPJ Parkinsons Dis. 2021. PMID: 34548497 Free PMC article.

7

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight.

Forloni G, La Vitola P, Cerovic M, Balducci C. Forloni G, et al. Prog Mol Biol Transl Sci. 2021;177:175-202. doi: 10.1016/bs.pmbts.2020.11.001. Epub 2020 Dec 15. Prog Mol Biol Transl Sci. 2021. PMID: 33453941

8

Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Gonzalez-Latapi P, Marras C. Gonzalez-Latapi P, et al. J Parkinsons Dis. 2022;12(s1):S29-S43. doi: 10.3233/JPD-223180. J Parkinsons Dis. 2022. PMID: 35661019 Free PMC article. Review.

9

LRRK2 as a target for modulating immune system responses.

Russo I, Bubacco L, Greggio E. Russo I, et al. Neurobiol Dis. 2022 Jul;169:105724. doi: 10.1016/j.nbd.2022.105724. Epub 2022 Apr 12. Neurobiol Dis. 2022. PMID: 35427743 Free article. Review.

10

Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages.

Ahmadi Rastegar D, Hughes LP, Perera G, Keshiya S, Zhong S, Gao J, Halliday GM, Schüle B, Dzamko N. Ahmadi Rastegar D, et al. NPJ Parkinsons Dis. 2022 Mar 28;8(1):34. doi: 10.1038/s41531-022-00297-9. NPJ Parkinsons Dis. 2022. PMID: 35347144 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results